These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25534736)

  • 1. Novel quorum-quenching agents promote methicillin-resistant Staphylococcus aureus (MRSA) wound healing and sensitize MRSA to β-lactam antibiotics.
    Kuo D; Yu G; Hoch W; Gabay D; Long L; Ghannoum M; Nagy N; Harding CV; Viswanathan R; Shoham M
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1512-8. PubMed ID: 25534736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics.
    Tan CM; Therien AG; Lu J; Lee SH; Caron A; Gill CJ; Lebeau-Jacob C; Benton-Perdomo L; Monteiro JM; Pereira PM; Elsen NL; Wu J; Deschamps K; Petcu M; Wong S; Daigneault E; Kramer S; Liang L; Maxwell E; Claveau D; Vaillancourt J; Skorey K; Tam J; Wang H; Meredith TC; Sillaots S; Wang-Jarantow L; Ramtohul Y; Langlois E; Landry F; Reid JC; Parthasarathy G; Sharma S; Baryshnikova A; Lumb KJ; Pinho MG; Soisson SM; Roemer T
    Sci Transl Med; 2012 Mar; 4(126):126ra35. PubMed ID: 22440737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Lactam Antibiotics Enhance the Pathogenicity of Methicillin-Resistant Staphylococcus aureus via SarA-Controlled Lipoprotein-Like Cluster Expression.
    Shang W; Rao Y; Zheng Y; Yang Y; Hu Q; Hu Z; Yuan J; Peng H; Xiong K; Tan L; Li S; Zhu J; Li M; Hu X; Mao X; Rao X
    mBio; 2019 Jun; 10(3):. PubMed ID: 31186320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitizing of β-lactam resistance by tannic acid in methicillin-resistant S. aureus.
    Kırmusaoğlu S
    World J Microbiol Biotechnol; 2019 Mar; 35(4):57. PubMed ID: 30900046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sol-gel silica controlled release thin films for the inhibition of methicillin-resistant Staphylococcus aureus.
    Bhattacharyya S; Agrawal A; Knabe C; Ducheyne P
    Biomaterials; 2014 Jan; 35(1):509-17. PubMed ID: 24099711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
    Tran TD; Do TH; Tran NC; Ngo TD; Huynh TN; Tran CD; Thai KM
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4555-60. PubMed ID: 22727643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity effects of combinations of cephalothin, dicloxacillin, imipenem, vancomycin and amikacin against methicillin-resistant Staphylococcus spp. strains.
    Miranda-Novales G; Leaños-Miranda BE; Vilchis-Pérez M; Solórzano-Santos F
    Ann Clin Microbiol Antimicrob; 2006 Oct; 5():25. PubMed ID: 17034644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection.
    Takata T; Miyazaki M; Futo M; Hara S; Shiotsuka S; Kamimura H; Yoshimura H; Matsunaga A; Nishida T; Ishikura H; Ishikawa T; Tamura K; Tsuji BT
    Scand J Infect Dis; 2013 Mar; 45(3):203-12. PubMed ID: 23113753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deimmunized Lysostaphin Synergizes with Small-Molecule Chemotherapies and Resensitizes Methicillin-Resistant
    Fang Y; Kirsch JR; Li L; Brooks SA; Heim S; Tan C; Eszterhas S; Cheng HD; Zhao H; Xiong YQ; Griswold KE
    Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of chemical genetic interaction networks resensitize MRSA to β-lactam antibiotics.
    Lee SH; Jarantow LW; Wang H; Sillaots S; Cheng H; Meredith TC; Thompson J; Roemer T
    Chem Biol; 2011 Nov; 18(11):1379-89. PubMed ID: 22118672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced susceptibility to vancomycin in methicillin resistant staphylococcus aureus: a time for action.
    Amatya R; Devkota P; Gautam A
    Nepal Med Coll J; 2014 Sep; 16(1):42-4. PubMed ID: 25799810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo anti-MRSA activities of nosokomycins.
    Uchida R; Hanaki H; Matsui H; Hamamoto H; Sekimizu K; Iwatsuki M; Kim YP; Tomoda H
    Drug Discov Ther; 2014 Dec; 8(6):249-54. PubMed ID: 25639304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining the dual antibacterial and regenerative activities of platelet-rich plasma with β-lactams to mitigate MRSA-infected skin wounds.
    Yang SC; Lin CF; Alshetaili A; Aljuffali IA; Chien MY; Fang JY
    Biomed Pharmacother; 2023 Sep; 165():115017. PubMed ID: 37327588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auxiliary factors: a chink in the armor of MRSA resistance to β-lactam antibiotics.
    Roemer T; Schneider T; Pinho MG
    Curr Opin Microbiol; 2013 Oct; 16(5):538-48. PubMed ID: 23895826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic susceptibility survey of blood-borne MRSA isolates in Japan from 2008 through 2011.
    Hanaki H; Cui L; Ikeda-Dantsuji Y; Nakae T; Honda J; Yanagihara K; Takesue Y; Matsumoto T; Sunakawa K; Kaku M; Tomono K; Fukuchi K; Kusachi S; Mikamo H; Takata T; Otsuka Y; Nagura O; Fujitani S; Aoki Y; Yamaguchi Y; Tateda K; Kadota J; Kohno S; Niki Y
    J Infect Chemother; 2014 Sep; 20(9):527-34. PubMed ID: 25066429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthesis and SAR study of phenylalanine-derived (Z)-5-arylmethylidene rhodanines as anti-methicillin-resistant Staphylococcus aureus (MRSA) compounds.
    Patel BA; Ashby CR; Hardej D; Talele TT
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5523-7. PubMed ID: 24012180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
    Desbois AP; Gemmell CG; Coote PJ
    Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotating Magnetic Field Increases β-Lactam Antibiotic Susceptibility of Methicillin-Resistant
    Woroszyło M; Ciecholewska-Juśko D; Junka A; Drozd R; Wardach M; Migdał P; Szymczyk-Ziółkowska P; Styburski D; Fijałkowski K
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The investigation of inhibiting quorum sensing and methicillin-resistant Staphylococcus aureus biofilm formation from Liriodendron hybrid.
    Tan X; Yang D; Yang G; Chen J; Dong W; Shi J; Jia A
    Pak J Pharm Sci; 2015 May; 28(3):903-8. PubMed ID: 26004723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.